Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Dainippon Pays Boston Biomedical $15M Up Front for Option to Phase I/II Cancer Candidate

BBI could receive $100 million in milestones if DSP takes on license for Japan and $55 million during negotiation period for U.S. and Canadian rights.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »